![]() |
Volumn 26, Issue 1, 2006, Pages 43-46
|
Mechanism of arsenic trioxide inhibiting angiogenesis in multiple myeloma.
a
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
ARSENIC TRIOXIDE;
BRAIN DERIVED NEUROTROPHIC FACTOR;
BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR;
ORGANOARSENIC DERIVATIVE;
OXIDE;
ARTICLE;
BIOSYNTHESIS;
CYTOLOGY;
DOSE RESPONSE;
ENDOTHELIUM CELL;
GENETICS;
HUMAN;
METABOLISM;
MULTIPLE MYELOMA;
NEOVASCULARIZATION (PATHOLOGY);
TUMOR CELL LINE;
VASCULARIZATION;
ANGIOGENESIS INHIBITORS;
ARSENICALS;
BRAIN-DERIVED NEUROTROPHIC FACTOR;
CELL LINE, TUMOR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ENDOTHELIAL CELLS;
HUMANS;
MULTIPLE MYELOMA;
NEOVASCULARIZATION, PATHOLOGIC;
OXIDES;
RECEPTOR, TRKB;
MLCS;
MLOWN;
|
EID: 33750098918
PISSN: 16720733
EISSN: None
Source Type: Journal
DOI: 10.1007/bf02828035 Document Type: Article |
Times cited : (8)
|
References (0)
|